TY - JOUR
T1 - Mechanical heart valves between myths and new evidence
T2 - a systematic review and meta-analysis
AU - Santarpino, Giuseppe
AU - Serraino, Giuseppe F
AU - Cardetta, Francesco
AU - Di Mauro, Michele
AU - De Feo, Marisa
AU - Menicanti, Lorenzo
AU - Paparella, Domenico
AU - Mastroroberto, Pasquale
AU - Sorrentino, Sabato
AU - Speziale, Giuseppe
AU - Pollari, Francesco
AU - Mauro, Marianna
AU - Torella, Michele
AU - Coscioni, Enrico
AU - Chello, Massimo
AU - Barili, Fabio
AU - Parolari, Alessandro
AU - Italian Group of Research for Outcome in Cardiac Surgery (GIROC)
PY - 2024/12/6
Y1 - 2024/12/6
N2 - AIMS: The use of mechanical valve prostheses in cardiac surgery remains a necessary and indicated intervention in a large number of patients. However, predicted results associated with their use, on which current guideline recommendations have been developed, are based on dated studies at risk of bias (e.g. use of old generation models, very high international normalized ratio regimes). METHODS: A comprehensive search in multiple electronic databases was conducted from January 1995 to January 2024 using predefined criteria. The primary outcomes included all-cause death, bleeding events and thromboembolic events (i.e. stroke) at follow-up. RESULTS: Overall, 38 studies were included in the meta-analysis. Cumulative meta-analysis results for mortality, thromboembolic events and bleeding events were initially extremely variable and tended to become more consistent over time. A meta-regression for the impact of age and sex on mortality showed no difference, whereas a meta-regression for the impact of age and sex on thromboembolic events and on bleeding events showed a higher risk in the elderly and in female patients, respectively. CONCLUSION: The lack of fundamental information on the type of anticoagulant treatment (e.g. dosage, monitoring method) in the studies published to date does not allow us to draw any definitive conclusions on the outcomes of mechanical valve prostheses. The most recent studies have provided more consistent results, which in the past were highly variable, probably due to overcoming the bias in the use of prosthetic models of different generations.
AB - AIMS: The use of mechanical valve prostheses in cardiac surgery remains a necessary and indicated intervention in a large number of patients. However, predicted results associated with their use, on which current guideline recommendations have been developed, are based on dated studies at risk of bias (e.g. use of old generation models, very high international normalized ratio regimes). METHODS: A comprehensive search in multiple electronic databases was conducted from January 1995 to January 2024 using predefined criteria. The primary outcomes included all-cause death, bleeding events and thromboembolic events (i.e. stroke) at follow-up. RESULTS: Overall, 38 studies were included in the meta-analysis. Cumulative meta-analysis results for mortality, thromboembolic events and bleeding events were initially extremely variable and tended to become more consistent over time. A meta-regression for the impact of age and sex on mortality showed no difference, whereas a meta-regression for the impact of age and sex on thromboembolic events and on bleeding events showed a higher risk in the elderly and in female patients, respectively. CONCLUSION: The lack of fundamental information on the type of anticoagulant treatment (e.g. dosage, monitoring method) in the studies published to date does not allow us to draw any definitive conclusions on the outcomes of mechanical valve prostheses. The most recent studies have provided more consistent results, which in the past were highly variable, probably due to overcoming the bias in the use of prosthetic models of different generations.
KW - Humans
KW - Heart Valve Prosthesis
KW - Thromboembolism/etiology prevention & control mortality
KW - Risk Factors
KW - Heart Valve Prosthesis Implantation/adverse effects instrumentation mortality
KW - Prosthesis Design
KW - Female
KW - Anticoagulants/adverse effects therapeutic use
KW - Risk Assessment/methods
KW - Male
KW - Treatment Outcome
KW - Hemorrhage
KW - Aged
KW - Middle Aged
KW - Heart Valve Diseases/surgery mortality physiopathology
U2 - 10.2459/JCM.0000000000001691
DO - 10.2459/JCM.0000000000001691
M3 - (Systematic) Review article
SN - 1558-2027
VL - 26
SP - 18
EP - 28
JO - Journal of Cardiovascular Medicine
JF - Journal of Cardiovascular Medicine
IS - 1
ER -